Search
Search Results
##search.searchResults.foundPlural##
-
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3569PDF: 1430HTML: 2722 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3320PDF: 1902HTML: 3696 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2328PDF: 1023HTML: 4983 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4177PDF: 1302HTML: 2119Table 1: 221 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1539PDF: 1008HTML: 512 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3045PDF: 1058HTML: 1422 -
SPHINGOMONAS PAUCIMOBILIS INFECTIONS IN CHILDREN: NOSOCOMIAL VERSUS COMMUNITY ACQUIRED INFECTIONS
1864PDF: 1055HTML: 2079cover: 202Table 1. Co-morbidities associated with Sphingomonas paucimobilis infections.: 207Figure 1. The antimicrobial susceptibility patterns of Sphingomonas paucimobilis isolated from clinical specimens: 1730title page: 207 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4494PDF: 956HTML: 1359Table1: 205 -
-
WHAT ARE FUNGAL INFECTIONS?
4336PDF: 2475HTML: 27699de Pauw: 263 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4870PDF: 1603HTML: 2267Untitled: 252Untitled: 266Untitled: 286Untitled: 236Untitled: 253 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1928PDF: 1147HTML: 10754Untitled: 213 -
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2427PDF: 997HTML: 11163 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5402PDF: 1377HTML: 2868Cover letter: 225 -
THE EMERGING RESISTANCE IN NOSOCOMIAL URINARY TRACT INFECTIONS: FROM THE PEDIATRICS PERSPECTIVE.
2178PDF: 995HTML: 255The emerging resistance in nosocomial urinary tract infections: from the pediatrics perspective: 263 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2309PDF: 756HTML: 2145Untitled: 250Untitled: 172Untitled: 204Untitled: 177Untitled: 195Untitled: 203Untitled: 209 -
-
-
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
202PDF: 678HTML: 64 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3810PDF: 1305HTML: 3931Untitled: 259Untitled: 291 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1777PDF: 828HTML: 880jdoe, table 2 infections CML .doc: 215jdoe, table 1 infections CML .doc: 202 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2517PDF: 1226HTML: 1071 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2237PDF: 1038HTML: 4096Cover Letter: 242Figure 1: 256Figure 2: 249Table 1: 230 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2474PDF: 1471HTML: 2021 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4416PDF: 1428HTML: 2188 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1887PDF: 762HTML: 431







